Activation of circulating TFH17 cells associated with activated naive and double negative 2 B cell expansion, and disease activity in systemic lupus erythematosus patients

被引:0
|
作者
Khunsri, Tipanan [1 ]
Thawornpan, Pongsakorn [1 ]
Tianpothong, Pachara [1 ]
Suangtamai, Thanitta [2 ]
Ngamjanyaporn, Pintip [2 ]
Leepiyasakulchai, Chaniya [1 ]
Wangriatisak, Kittikorn [1 ]
Pisitkun, Prapaporn [2 ]
Chootong, Patchanee [1 ]
机构
[1] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Bangkok, Thailand
[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Div Allergy Immunol & Rheumatol, 270 Rama 6 Rd, Bangkok, Thailand
关键词
Systemic lupus erythematosus; Activated na & iuml; ve B cells; Double negative 2 B cells; Follicular helper T cells; HELPER T-CELLS; MEMORY; DIFFERENTIATION; EXPRESSION; ANTIGENS; SUBSET; LIGAND; IL-21;
D O I
10.1186/s13075-024-03394-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundSystemic lupus erythematosus (SLE) is the quintessential autoimmune disease, as it is characterized by hyperactivity of CD4+ T cells and subsequently drives lupus pathology. Follicular helper T (TFH) cells play an important role in B cell maturation and antibody production. However, which specific subset of cTFH cells drives B cell function and contributes to the development of anti-dsDNA antibodies and SLE pathogenesis remains unclear.MethodsPeripheral blood mononuclear cells from SLE patients with inactive (n = 11) and active (n = 21) were used to determine and detect frequencies and phenotypes of circulating TFH cells (cTFH), memory cTFH, and B cell subsets. The correlations among cTFH cell subsets and phenotypes, B cell subsets, anti-dsDNA autoantibodies, and clinical parameters were analyzed.ResultsIn subjects with active SLE, cTFH1 and cTFH17 cells were significantly expanded and activated. These expanded cTFH cells expressed memory phenotypes; cTFH1 cells were predominantly central memory (CM) type, while cTFH17 cells were largely effector memory (EM) type. Phenotyping B cell subsets in these patients showed increased frequencies of aNAV and DN2 B cells. Clinically, ICOS+ cTFH1, ICOS+ cTFH17 cells, and SLEDAI-2k scores were found to be correlated. Analysis of cTFH-B cell relationship revealed positive correlations among ICOS+ cTFH1 cells, aNAV B cells, and anti-dsDNA antibodies. Activation of ICOS+ cTFH17 cells was significantly related to the expansion of aNAV and DN2 B cells. The presence of CM cells in cTFH1 and cTFH17 subsets was correlated with aNAV and DN2 B cell frequencies.ConclusionSLE cTFH cells were found to be polarized toward cTFH1 and cTFH17 cells; activation of these cTFH subsets was significantly associated with disease activity score, aNAV, DN2 B cell expansion, and anti-dsDNA antibody level. Thus, the interactions among cTFH1, cTFH17, and B cells likely contribute to the development of autoantibodies and the pathogenesis in SLE.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season
    Pertovaara, M.
    Hasan, T.
    Raitala, A.
    Oja, S. S.
    Yli-Kerttula, U.
    Korpela, M.
    Hurme, M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 150 (02) : 274 - 278
  • [32] Study the relationship between vitamin A deficiency, T helper 17, regulatory T cells, and disease activity in patients with systemic lupus erythematosus
    Dina S. Fettouh
    Dalia S. Saif
    Saga F. El Gazzar
    Ahmed A. Sonbol
    Egyptian Rheumatology and Rehabilitation, 2019, 46 (4) : 244 - 250
  • [33] RNASE2 Mediates Age-Associated B Cell Expansion Through Monocyte Derived IL-10 in Patients With Systemic Lupus Erythematosus
    Zhu, Yantong
    Tang, Xiaojun
    Xu, Yang
    Wu, Si
    Liu, Weilin
    Geng, Linyu
    Ma, Xiaolei
    Tsao, Betty P.
    Feng, Xuebing
    Sun, Lingyun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] BCL-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity
    Miret, C
    Font, J
    Molina, R
    Garcia-Carrasco, M
    Filella, X
    Ramos, M
    Cervera, R
    Ballesta, A
    Ingelmo, M
    ANTICANCER RESEARCH, 1999, 19 (4B) : 3073 - 3076
  • [35] CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus
    Patschan, S.
    Dolff, S.
    Kribben, A.
    Duerig, J.
    Patschan, D.
    Wilde, B.
    Specker, C.
    Philipp, T.
    Witzke, O.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 145 (02) : 235 - 242
  • [36] Mechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus Erythematosus
    Lai, Zhi-Wei
    Borsuk, Rebecca
    Shadakshari, Ashwini
    Yu, Jianghong
    Dawood, Maha
    Garcia, Ricardo
    Francis, Lisa
    Tily, Hajra
    Bartos, Adam
    Faraone, Stephen V.
    Phillips, Paul
    Perl, Andras
    JOURNAL OF IMMUNOLOGY, 2013, 191 (05) : 2236 - 2246
  • [37] DISEASE FLARES AFTER SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS ARE ASSOCIATED WITH DISEASE ACTIVITY BEFORE VACCINATION
    Kikuchi, J.
    Kondo, Y.
    Kojima, S.
    Kasai, S.
    Sakai, Y.
    Takeshita, M.
    Hiramoto, K.
    Saito, S.
    Fukui, H.
    Suzuki, K.
    Kaneko, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1093 - 1093
  • [38] Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients
    Ciolkiewicz, Mariusz
    Kuryliszyn-Moskal, Anna
    Klimiuk, Piotr Adrian
    CLINICAL RHEUMATOLOGY, 2010, 29 (02) : 175 - 180
  • [39] Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients
    Mariusz Ciołkiewicz
    Anna Kuryliszyn-Moskal
    Piotr Adrian Klimiuk
    Clinical Rheumatology, 2010, 29 : 175 - 180
  • [40] Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients
    Carrion, F.
    Nova, E.
    Ruiz, C.
    Diaz, F.
    Inostroza, C.
    Rojo, D.
    Monckeberg, G.
    Figueroa, F. E.
    LUPUS, 2010, 19 (03) : 317 - 322